GO
Loading...

Big Pharma Lost Its Luster?

Monday, 25 Mar 2013 | 6:25 PM ET

Mad Money host Jim Cramer offers reasons for investors to shift away from Europe. Big pharma stocks' growth has slowed, and they've passed the baton to biotechs like Celgene.